Tumor-infiltrating Lymphocytes independently predict the Prognosis of triple-negative Breast Cancer

被引:0
|
作者
Krome, Susanne
机构
关键词
D O I
10.1055/a-2317-6029
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Patients with triple-negative breast cancer have a high risk of recurrence and metastasis even in early stages. Adjuvant and neoadjuvant chemotherapy reduces the probability. A high proportion of tumor-infiltrating lymphocytes (TIL) has been confirmed as a favorable biomarker in women treated with chemotherapy. The retrospective meta-analysis now shows an independent prognostic value of TIL in patients who were treated exclusively locoregionally.
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Computational scoring of tumor infiltrating lymphocytes in triple-negative breast cancer
    Amgad, M.
    Sarkar, A.
    Srinivas, C.
    Redman, R.
    Ratra, S.
    Bechert, C. J.
    Calhoun, B. C.
    Mrazeck, K.
    Kurkure, U.
    Cooper, L. A.
    Barnes, M.
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [42] A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer
    Criscitiello, C.
    Bayar, M. A.
    Curigliano, G.
    Symmans, F. W.
    Desmedt, C.
    Bonnefoi, H.
    Sinn, B.
    Pruneri, G.
    Vicier, C.
    Pierga, J. Y.
    Denkert, C.
    Loibl, S.
    Sotiriou, C.
    Michiels, S.
    Andre, F.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 (01) : 162 - 169
  • [43] Radiomics features for assessing tumor-infiltrating lymphocytes correlate with molecular traits of triple-negative breast cancer
    Su, Guan-Hua
    Xiao, Yi
    Jiang, Lin
    Zheng, Ren-Cheng
    Wang, He
    Chen, Yan
    Gu, Ya-Jia
    You, Chao
    Shao, Zhi-Ming
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [44] Simple assessment reveals the importance of distribution and density of tumor-infiltrating lymphocytes in triple-negative breast cancer
    Hida, A. I.
    Mizuno, Y.
    Ueda, N.
    Oshiro, Y.
    Sugita, A.
    Matsukage, S.
    Maeda, T.
    Kito, K.
    Ohtsuki, Y.
    Aogi, K.
    [J]. BREAST, 2017, 32 : S33 - S34
  • [45] The role of tumor-infiltrating lymphocytes in triple-negative breast cancer and the research progress of adoptive cell therapy
    Li, Ruonan
    Cao, Lili
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [46] Radiomics features for assessing tumor-infiltrating lymphocytes correlate with molecular traits of triple-negative breast cancer
    Guan-Hua Su
    Yi Xiao
    Lin Jiang
    Ren-Cheng Zheng
    He Wang
    Yan Chen
    Ya-Jia Gu
    Chao You
    Zhi-Ming Shao
    [J]. Journal of Translational Medicine, 20
  • [47] An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer
    Bai, Yalai
    Cole, Kimberly
    Martinez-Morilla, Sandra
    Ahmed, Fahad Shabbir
    Zugazagoitia, Jon
    Staaf, Johan
    Bosch, Ana
    Ehinger, Anna
    Nimeus, Emma
    Hartman, Johan
    Acs, Balazs
    Rimm, David L.
    [J]. CLINICAL CANCER RESEARCH, 2021, 27 (20) : 5557 - 5565
  • [48] Tumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer: The Future of Immune Targeting
    Garcia-Teijido, Paula
    Luque Cabal, Maria
    Pelaez Fernandez, Ignacio
    Fernandez Perez, Yolanda
    [J]. CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2016, 10 : 31 - 39
  • [49] Clinical Significance of Stromal Tumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer
    Goel, Kanika
    Carter, Gloria
    Clark, Beth
    Fine, Jeffrey
    Yu, Jing
    Harinath, Lakshmi
    Villatoro, Tatiana
    Bhargava, Rohit
    [J]. MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 117 - 119
  • [50] Clinical Significance of Stromal Tumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer
    Goel, Kanika
    Carter, Gloria
    Clark, Beth
    Fine, Jeffrey
    Yu, Jing
    Harinath, Lakshmi
    Villatoro, Tatiana
    Bhargava, Rohit
    [J]. LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 117 - 119